51 results
8-K
EX-10.1
qfktn 0qb
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
8-K
EX-99.1
lqia6umt13 g3oqvah2
6 Apr 21
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020
4:30pm
8-K
EX-99.1
tmkeafp7qzi a7
25 Feb 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
yjgj ktnav216
12 Feb 21
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
5:29pm
8-K
EX-99.1
9so94a61
6 Jan 21
CURE Pharmaceutical Receives FDA Approval for its IND Application
9:15am
8-K/A
EX-99.2
bw4ru8zpc
15 Dec 20
Financial Statements and Exhibits
9:15am
8-K
EX-99.1
1ak2eo9d jsiumb34
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm